The document provides an analysis of THC's unsecured bonds, rating them as a Buy. It discusses the potential yield and risks associated with these bonds, including the impact of asset sales and leverage on THC's financial profile. The document also highlights the company's hospital footprint and diversification strategy through USPI. Risks to the bond rating are identified, including operational performance and asset sales.
doj/DataSet10/EFTA01385384.pdf
{"title":"HY Corporate Credit - Top Picks","document_date":"2018-01-03","document_type":"financial","key_organizations":["THC","Deutsche Bank Securities Inc."],"reference_numbers":["DB-SDNY-0086668","SDNY_GM_00232852","EFTA01385384"]}